Common Contracts
3 similar Consulting Agreement contracts by Nabriva Therapeutics PLC
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • April 17th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is effective as of February 1, 2023 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington PA 19304 (“Company”), and Christine Guico-Pabia having an address at [**] (“Consultant”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • May 6th, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is dated as of May 3, 2021 and effective as of May 3, 2021 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington, PA 19034 (“Company”), and Jennifer Schranz having an address at [**] (“Consultant”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • March 11th, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is dated as of March 9, 2021 and effective as of March 15, 2021 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 1000 Continental Drive, Suite 600, King of Prussia, Pennsylvania 19406 (“Company”), and Sender Consulting LLC having an address at [**] (“Consultant”).
